SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (420)3/13/1999 2:03:00 PM
From: Brasco One  Read Replies (1) | Respond to of 2515
 
Waiting to see if IMCL was mentioned in Barrons...

please keep us posted w/ any articles.



To: QuietWon who wrote (420)3/29/1999 9:02:00 AM
From: CPAMarty  Read Replies (1) | Respond to of 2515
 
They are talking about mergers in the big drug/biotech stocks on CNBC this morning (in addition to BP/AMOCO and AR). There would be synergies for IMCL involving obtaining FDA approval and ramping up production quickly. Since IMCL has N. American rights, could a drug company other than Merck KGaA be interested? Before the first round of Phase III results on C225 are in?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News